Shimamura F

No ORCID on file · 2 papers in corpus
rct 2026
Linzagolix for Japanese women with uterine fibroids: a randomized, double-blind, placebo-controlled, phase 3 trial.
F&S reports ·doi:10.1016/j.xfre.2026.07.003

ObjectiveTo evaluate the efficacy, safety, and pharmacodynamics of linzagolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, in patients with heavy menstrual bleeding (HMB) and pain because of uterine fibroids.DesignPha…

rct 2026
Linzagolix versus leuprorelin in Japanese women with uterine leiomyomas: a phase 3, randomized, active-controlled, non-inferiority trial
Human reproduction (Oxford, England) ·doi:10.1093/humrep/deag106

STUDY QUESTION: How does the efficacy of linzagolix (a gonadotropin-releasing hormone [GnRH] receptor antagonist) compare with leuprorelin (a GnRH agonist) for the treatment of heavy menstrual bleeding (HMB) in patients with uterine leiomyo…